Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA

UnknownOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Gastric Cancer
Interventions
GENETIC

whole genomic methylation and fragmentation profile analysis of cfDNA

The assay for gastric cancer early detection will be built based on low-depth methylone sequencing followed with a multi-dimensional model construction with analysing several features such as methylation, fragmentation, and chromosomal copy number alternation.

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Air Force Military Medical University (Xijing Hospital), Xi'an

All Listed Sponsors
collaborator

The First Affiliated Hospital of Air Force Medicial University

OTHER

lead

GeneCast Biotechnology Co., Ltd.

INDUSTRY

NCT05668910 - Gastric Cancer Early Detection by Multi-dimensional Analysis of cfDNA | Biotech Hunter | Biotech Hunter